inmunebio.jpg
INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy
January 25, 2023 07:45 ET | INmune Bio, Inc.
Boca Raton, Florida, Jan. 25, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...
Logo.png
Univest Client INmune Bio, Inc. ("INMB”) to Ring NASDAQ Closing Bell
April 09, 2019 13:28 ET | Univest Securities, LLC
New York, April 09, 2019 (GLOBE NEWSWIRE) -- Univest Securities client INmune Bio, Inc. (INmune Bio) (NASDAQ: INMB), a clinical stage immunology biotech company developing therapies in patients’...
Logo.png
INmune Bio Co-Founders to Present at World Immunotherapy Congress during the Festival of Biologics San Diego
February 26, 2019 09:30 ET | INmune Bio, Inc.
Presentations to address the role of the innate immune system in treating cancer LA JOLLA, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused...
Logo.png
INmune Bio Awarded a $1 Million Grant for the Development of XPro1595 for the treatment of Alzheimer’s Disease
February 11, 2019 08:00 ET | INmune Bio, Inc.
The Alzheimer’s Association awarded INmune Bio the Part the Cloud to RESCUE grant to target neuroinflammation in Alzheimer’s Disease LA JOLLA, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- INmune...
Logo.png
INmune Bio to Present at BIO CEO & Investor Conference
February 06, 2019 09:00 ET | INmune Bio, Inc.
LA JOLLA, CA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (Nasdaq: INMB) (“INmune” or the “Company”), an immunotherapy company focused on developing therapies that harness the patient’s...
Logo.png
INmune Bio Inc. Announces Closing of Initial Public Offering and Trading on the Nasdaq Capital Market Under the Ticker Symbol “INMB”
February 04, 2019 08:55 ET | INmune Bio, Inc.
LA JOLLA, CA, Feb. 04, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (“INmune” or the “Company”), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system...